Innate pharma files its 2024 universal registration document (document d'enregistrement universel) and 2024 annual report on form 20-f

Marseille, france--(business wire)-- #anket--regulatory news: innate pharma sa (euronext paris: iph; nasdaq: ipha) (“innate” or the “company”) today announced the filing of its 2024 universal registration document (document d'enregistrement universel) for the year ending december 31, 2024 with the french market authority “autoritÉ des marchÉs financiers” (“amf”) on april 30, 2025. it can be downloaded (in french) on the company's website and on the amf's website. the company also announced today the fil.
UVV Ratings Summary
UVV Quant Ranking